How Long Is Your Plan Willing To Throw Away Thousands of Dollars Per Script For An MS Drug? ____________ Review your Plan’s most expensive therapeutic categories, and it’s virtually certain you’ll
If your Plan wants to decrease and control its costs, you need your PBM to take advantage of every Specialty Drug savings opportunity. Unfortunately, many - if not most -
Any Plan that wants to control its prescription coverage costs needs to control the "days supply" of Specialty Drugs that will be dispensed by its PBM. Your Plan can't afford
We're pleased to report that the National Prescription Coverage Coalition has yet again achieved striking savings for our Coalition Members. Based on year-end analyses, our Coalition Members decreased their prescription
Remember when several drug manufacturers promised last year to limit their drug price increases to single digits and claimed other drug manufacturers drastically increasing their drug prices were "outliers"? If those manufacturers'
We're thrilled to report yet again that the National Prescription Coverage Coalition has achieved striking savings for our Coalition Members. Based on year-end analyses, our Coalition Members decreased their prescription coverage costs by approximately 20% to
If your Plan wants to control its prescription coverage costs - and minimize disruption to your plan beneficiaries - your Plan needs to act preemptively to block certain drugs before
If you missed the latest example of drug manufacturer abuse, you need to learn about Allergan's Restasis antics, understand your Plan's resulting costs, and take action in response. Why? Because
PBMs' questionable rebate conduct, every Plan administrator and fiduciary should consider filing a lawsuit against your PBM seeking an "accounting". As a Plan administrator or fiduciary, you're charged with ensuring
For years, every PBM has refused to disclose the "rebates" that it earns on a drug-by-drug basis. As a result, no one has been able to detect the "net cost"
Horizon Pharma - the manufacturer of three extremely expensive drugs - Vimovo, Duexis and Pennsaid – just released its Quarterly Earnings Report causing its stock to plummet. The Report should
We're thrilled to report that yet another Coalition Member that followed our Coalition's recommendations and took aggressive steps to control its prescription coverage costs has now achieved a 16% cost
Plan Administrators: Have you ever heard of "switch operators"? Do you have any idea what they do? Most important, do you realize that drug manufacturers are surreptitiously paying switch operators
If you've been preoccupied with Trump's latest cabinet appointments, you may have missed the news about a new program sponsored by Eli Lilly and Express Scripts. With great fanfare, the
Recently, Novo Nordisk's President became the second drug manufacturer to make a "Single Digit Price Increase Pledge." Replicating Allergan's vow three months ago, Novo's Jakob Riis promised that Novo would
For more than a decade, our firm has called on every PBM to identify all rebates (and other monies) the PBM is receiving from manufacturers - as well as the
If you examine your Heath Plan's claims data, it's extremely likely you'll discover that Crestor is costing your Plan a small fortune. Typically, Crestor represents more than 1% of
If you examine your claims data, you'll likely discover that among your "Top 50 Most Expensive Drugs" is a line item for generic "metformin HCL ER". Metformin HCL is a
We previously wrote about new drugs' dangers, and received many requests for additional information. Accordingly, we thought our readers would benefit from the following additional information reflecting why all health
The latest FDA Black Box Warning about hepatitis C treatments demonstrates why it's imperative that your Plan implement methods for protecting your beneficiaries against the dangers of new drugs. After
Most health plans' prescription coverage programs allow plan beneficiaries to purchase drugs at virtually all retail pharmacies in the United States, regardless of the prices charged by those pharmacies. But
